Global Pulmonary Fibrosis Biomarkers Market Size, Share, Forecast 2023 – 2033
The Global Pulmonary Fibrosis Biomarkers Market Size is Anticipated to Exceed USD 6.1 Billion by 2033, Growing at a CAGR of 4.3% from 2023 to 2033.Pulmonary fibrosis biomarkers are molecules, substances, or characteristics found in biological samples such as blood, sputum, or lung tissue that can be used to determine the presence, severity, progression, or response to treatment of pulmonary fibrosis. In addition, with the lung's condition Idiopathic pulmonary fibrosis (IPF) is dangerous.